Table 4.
Tests typically used to establish a COPD diagnosis, by physician type: Continuing to Confront COPD International Survey, 2012–2013
Diagnostic test | PCP (n=971) % |
RS (n=336) % |
P-value* | ||||
---|---|---|---|---|---|---|---|
Yes | No | Not available | Yes | No | Not available | ||
Spirometry testing | 82 | 2 | 16 | 100 | 0 | 0 | <0.001 |
Prebronchodilator | 22 | 15 | |||||
Postbronchodilator | 7 | 21 | |||||
Both | 69 | 64 | |||||
Peak expiratory flow | 55 | 29 | 16 | 43 | 51 | 6 | <0.001 |
Bronchodilator responsiveness | 68 | 23 | 9 | 80 | 19 | 2 | <0.001 |
Oral corticosteroid responsiveness | 38 | 52 | 9 | 28 | 65 | 7 | <0.001 |
Chest X-ray | 76 | 11 | 13 | 89 | 10 | 2 | <0.001 |
Blood test/oximetry | 45 | 32 | 23 | 69 | 27 | 4 | <0.001 |
CAT/CT/MRI scans | 21 | 53 | 25 | 44 | 51 | 5 | <0.001 |
Patient-reported outcomes (eg, dyspnea measure or COPD-assessment test) | 67 | 28 | 5 | 81 | 18 | 1 | <0.001 |
Note:
P-value comparing PCP to RS for responses of yes versus no/not available, adjusted for country and awareness of GOLD global strategy.
Abbreviations: COPD, chronic obstructive pulmonary disease; PCP, primary care physician; RS, respiratory specialist; CAT, computerized axial tomography; CT, computerized tomography; MRI, magnetic resonance imaging; GOLD, Global initiative for chronic Obstructive Lung Disease.